KindlyMD (NASDAQ:NAKA – Get Free Report) and Solana (NASDAQ:HSDT – Get Free Report) are both small-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, analyst recommendations and institutional ownership.
Analyst Ratings
This is a breakdown of recent recommendations and price targets for KindlyMD and Solana, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| KindlyMD | 1 | 0 | 3 | 0 | 2.50 |
| Solana | 1 | 1 | 2 | 0 | 2.25 |
KindlyMD presently has a consensus target price of $19.00, indicating a potential upside of 452.33%. Solana has a consensus target price of $3.50, indicating a potential upside of 134.11%. Given KindlyMD’s stronger consensus rating and higher possible upside, equities research analysts clearly believe KindlyMD is more favorable than Solana.
Risk & Volatility
KindlyMD has a beta of 16.03, suggesting that its share price is 1,503% more volatile than the S&P 500. Comparatively, Solana has a beta of 1.1, suggesting that its share price is 10% more volatile than the S&P 500.
Institutional and Insider Ownership
18.6% of Solana shares are owned by institutional investors. 24.1% of KindlyMD shares are owned by insiders. Comparatively, 14.4% of Solana shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares KindlyMD and Solana’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| KindlyMD | -1,067.93% | -73.53% | -46.28% |
| Solana | 2,040.43% | 128.12% | 122.51% |
Earnings and Valuation
This table compares KindlyMD and Solana”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| KindlyMD | $1.82 million | 34.68 | -$52.23 million | ($14.98) | -0.23 |
| Solana | $14.73 million | 6.38 | -$40.89 million | $3.74 | 0.40 |
Solana has higher revenue and earnings than KindlyMD. KindlyMD is trading at a lower price-to-earnings ratio than Solana, indicating that it is currently the more affordable of the two stocks.
Summary
Solana beats KindlyMD on 8 of the 14 factors compared between the two stocks.
About KindlyMD
KindlyMD is a Utah-based healthcare company that provides outpatient medical services, with a focus on integrated care. Its offerings include primary care, behavioral health and treatment for substance use disorders, along with care coordination intended to connect patients with appropriate services. The company serves patients through clinics in Utah and has emphasized care for people with complex or ongoing health needs. KindlyMD combined with Nakamoto Holdings in 2025; the resulting company trades on Nasdaq under the symbol NAKA.
About Solana
Solana Company (NASDAQ: HSDT) is a publicly traded company focused on a digital-asset treasury strategy centered on SOL, the native token of the Solana blockchain. It is a corporate holder of Solana-related digital assets, rather than the operator of the Solana network. The company was formerly Helius Medical Technologies, a medical technology business that developed the Portable Neuromodulation Stimulator (PoNS), a device designed to support rehabilitation for people with certain neurological conditions.
Receive News & Ratings for KindlyMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KindlyMD and related companies with MarketBeat.com's FREE daily email newsletter.
